Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000897.v1.p1.1
Item
Patients were selected if they were diagnosed with an ovarian tumor of stage 1 of 2. Patients were excluded if they had a known family history of BRCA1 or BRCA2 germline mutation or if they had a positive test for germline mutation in their clinical record. These patients were required to be chemo-naive prior to collection of the tumor tissue.
boolean
C1512693 (UMLS CUI [1,1])
C1706256 (UMLS CUI [1,2])
C0029925 (UMLS CUI [1,3])
C0680251 (UMLS CUI [2,1])
C0241889 (UMLS CUI [2,2])
C1511022 (UMLS CUI [2,3])
C1511024 (UMLS CUI [2,4])
C0206530 (UMLS CUI [2,5])
Elig.phs000897.v1.p1.2
Item
The current release of this study focusses on 17 patients with serous carcinoma and stage 1 or 2 and with high grade (3 or 4).
boolean
C2348563 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C0440743 (UMLS CUI [1,3])
C0019638 (UMLS CUI [1,4])